Tissue Donation for Myoblast Culture
1 other identifier
interventional
24
1 country
1
Brief Summary
Analyze human skeletal muscle and learn more about the ability of adult muscle to produce myoblasts (young muscle cells).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 6, 2010
CompletedFirst Posted
Study publicly available on registry
May 10, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedMarch 4, 2019
March 1, 2019
1.3 years
May 6, 2010
March 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cell expansion
The goal of this pilot study is to obtain small amounts of human skeletal muscle that would normally be discarded during gynecologic surgery and instead conserve this tissue for laboratory analysis.
weekly
Study Arms (1)
Tissue Donation
EXPERIMENTALThis study will involve females over 18 who are scheduled to undergo elective surgery. These patients will be screened for participation in this study, which will only involve the collection of discarded tissue.
Interventions
Females over 18 who are scheduled to undergo elective surgery will have discarded tissue collected.
Eligibility Criteria
You may qualify if:
- \- Age: 18 years of age or older Female Patients who are already electing to undergo obstetric or gynecologic surgery (either vaginal or abdominal) for a preexisting condition.
You may not qualify if:
- \- Active systemic or pelvic infections including HIV HBV HCV, STD, PID Patients with tumors, metastatic disease or treated with cytostatics Patients undergoing emergency surgical procedures Unconscious or mentally incapable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCI Women's Healthcare
Orange, California, 92868, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felicia Lane, MD
UCI Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 6, 2010
First Posted
May 10, 2010
Study Start
October 1, 2008
Primary Completion
February 1, 2010
Study Completion
June 1, 2012
Last Updated
March 4, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share